General Counsel

Min Ding provides leadership on legal affairs, business development, intellectual property, and risk management at IAVI. He advises the board of directors, CEO, COO, and other senior management team members on governance and strategy, and is responsible for all legal matters at IAVI, including structuring and negotiating IAVI’s collaborations with academic, industry, and public sector partners to ensure that products developed will be globally accessible and affordable.

Prior to joining IAVI, Ding practiced law for 20 years in law firms and pharmaceutical companies, building tremendous relevant experience and a strong set of core legal capabilities. Most recently, he spent eight years at The Medicines Company (later acquired by Novartis), a specialty pharmaceutical company, with increasing responsibilities and most recently as Vice President, Innovation Leader and Corporate Counsel.

Min earned an undergraduate degree from Beijing University, a Ph.D. in microbiology and molecular genetics from the University of Vermont, and J.D. from Columbia University.